Chinese drugmaker CF PharmTech surged 100.8% in Hong Kong grey market.
CF PharmTech reported revenue of nearly 610 million yuan last year, up 9% year-on-year. Its profit for the year totaled 21.09 million yuan, down 33.5%. Its first-quarter revenue this year reached 136 million yuan, down 2.7% year-over-year, while its profit for the period more than doubled to 12.82 million yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.